Corbion and MedinCell form joint venture to supply resorbable polymers for controlled drug release
| Source: Corbion
Corbion and MedinCell are establishing a 50/50 joint venture for the supply of PEG (polyethyleneglycol) and PLA (polylactic acid) based co-polymers in the field of controlled release drug delivery.
Attachments
Recommended Reading
-
Corbion quarterly financial results Q2 H1 2026
Read More